Search Results - "VAN RIEL, Piet L"

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration by Chatzidionysiou, Katerina, Lie, Elisabeth, Nasonov, Evgeny, Lukina, Galina, Hetland, Merete Lund, Tarp, Ulrik, Ancuta, Ioan, Pavelka, Karel, Nordström, Dan C, Gabay, Cem, Canhão, Helene, Tomsic, Matija, van Riel, Piet L C M, Gomez-Reino, Juan, Kvien, Tore K, van Vollenhoven, Ronald F

“…The approved dose of rituximab (RTX) in rheumatoid arthritis is 1000 mg × 2, but some data have suggested similar clinical efficacy with 500 mg × 2. The…”
Get full text

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis by Crowson, Cynthia S, Rollefstad, Silvia, Kitas, George D, van Riel, Piet L C M, Gabriel, Sherine E, Semb, Anne Grete

“…Cardiovascular disease (CVD) risk calculators designed for use in the general population do not accurately predict the risk of CVD among patients with…”
Get full text

Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis by Toonen, Erik J M, Gilissen, Christian, Franke, Barbara, Kievit, Wietske, Eijsbouts, Agnes M, den Broeder, Alfons A, van Reijmersdal, Simon V, Veltman, Joris A, Scheffer, Hans, Radstake, Timothy R D J, van Riel, Piet L C M, Barrera, Pilar, Coenen, Marieke J H

“…So far, there are no means of identifying rheumatoid arthritis (RA) patients who will fail to respond to tumour necrosis factor blocking agents (anti-TNF),…”
Get full text

Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritis by Oude Voshaar, Martijn A H, ten Klooster, Peter M, Glas, Cees A W, Vonkeman, Harald E, Taal, Erik, Krishnan, Eswar, Moens, Hein J Bernelot, Boers, Maarten, Terwee, Caroline B, van Riel, Piet L C M, van de Laar, Mart A F J

“…To calibrate the Dutch-Flemish version of the PROMIS physical function (PF) item bank in patients with rheumatoid arthritis (RA) and to evaluate cross-cultural…”
Get full text

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis by Crowson, Cynthia S, Rollefstad, Silvia, Kitas, George D, van Riel, Piet L C M, Gabriel, Sherine E, Semb, Anne Grete

“…[This corrects the article DOI: 10.1371/journal.pone.0174656.]…”
Get full text

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis by Crowson, Cynthia S, Rollefstad, Silvia, Ikdahl, Eirik, Kitas, George D, van Riel, Piet L C M, Gabriel, Sherine E, Matteson, Eric L, Kvien, Tore K, Douglas, Karen, Sandoo, Aamer, Arts, Elke, Wållberg-Jonsson, Solveig, Innala, Lena, Karpouzas, George, Dessein, Patrick H, Tsang, Linda, El-Gabalawy, Hani, Hitchon, Carol, Ramos, Virginia Pascual, Yáñez, Irazú Contreras, Sfikakis, Petros P, Zampeli, Evangelia, Gonzalez-Gay, Miguel A, Corrales, Alfonso, Laar, Mart van de, Vonkeman, Harald E, Meek, Inger, Semb, Anne Grete

“…Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular disease (CVD). We aimed to assess the impact of CVD risk factors, including…”
Get more information

TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop by Wenink, Mark H, Santegoets, Kim C. M, Broen, Jacobus C. A, van Bon, Lenny, Abdollahi-Roodsaz, Shahla, Popa, Calin, Huijbens, Richard, Remijn, Thijs, Lubberts, Erik, van Riel, Piet L. C. M, van den Berg, Wim B, Radstake, Timothy R. D. J

“…TLR2 plays an important role in the removal of Gram-positive bacteria; contrastingly, it also appears to have important protective effects against unrestrained…”
Get full text

Induction of nocebo and placebo effects on itch and pain by verbal suggestions by van Laarhoven, Antoinette I.M., Vogelaar, Michiel L., Wilder-Smith, Oliver H., van Riel, Piet L.C.M., van de Kerkhof, Peter C.M., Kraaimaat, Floris W., Evers, Andrea W.M.

“…Physical complaints, such as pain, can be effectively reduced by placebo effects through induction of positive expectations, or increased by nocebo effects…”
Get full text

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study by Arts, Elke Ea, Fransen, Jaap, Den Broeder, Alfons A, van Riel, Piet L C M, Popa, Calin D

“…Systemic inflammation appears to contribute to the excess risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA). The objective of this study was to…”
Get more information

Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker by Siemons, Liseth, Vonkeman, Harald E., ten Klooster, Peter M., van Riel, Piet L. C. M., van de Laar, Mart A. F. J.

“…This paper aims to examine the interchangeability of the disease activity score in 28 joints (DAS28)-erythrocyte sedimentation rate (ESR) and DAS28-CRP scores…”
Get full text

Psychophysiological responses to stress after stress management training in patients with rheumatoid arthritis by de Brouwer, Sabine J M, Kraaimaat, Floris W, Sweep, Fred C G J, Donders, Rogier T, Eijsbouts, Agnes, van Koulil, Saskia, van Riel, Piet L C M, Evers, Andrea W M

“…Stress management interventions may prove useful in preventing the detrimental effects of stress on health. This study assessed the effects of a stress…”
Get full text

Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia by van Santen, Susanne, van Dongen‐Lases, Edmée C., de Vegt, Femmie, Laarakkers, Coby M. M., van Riel, Piet L. C. M., van Ede, Annelies E., Swinkels, Dorine W.

“…Objective To explore the utility of the novel iron indices hepcidin, reticulocyte hemoglobin content (Ret‐Hgb), and erythrocyte (red blood cell) hemoglobin…”
Get full text

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients by Arts, Elke E A, Fransen, Jaap, den Broeder, Alfons A, Popa, Calin D, van Riel, Piet L C M

“…Disease duration and disease activity may be associated with an increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA). The objectives of…”
Get more information

Increased fascial thickness of the deltoid muscle in dermatomyositis and polymyositis: An ultrasound study by Bhansing, Kavish J., Van Rosmalen, Marieke H., Van Engelen, Baziel G., Vonk, Madelon C., Van Riel, Piet L., Pillen, Sigrid

“…ABSTRACT Introduction: We investigated the use of ultrasound to detect fascial thickening of the deltoid, vastus lateralis (VL), and rectus femoris (RF)…”
Get full text

Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome by Schipper, Lydia G., van Hulst, Laura T. C., Grol, Richard, van Riel, Piet L. C. M., Hulscher, Marlies E. J. L., Fransen, Jaap

“…Objectives. Tight control studies including regular assessments of disease activity have shown that this approach has beneficial effects on disease activity,…”
Get full text

Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis by Bhansing, Kavish J, VAN Rosmalen, Marieke H, VAN Engelen, Baziel G, VAN Riel, Piet L, Pillen, Sigrid, Vonk, Madelon C

Get full text

Adherence Rates and Associations with Nonadherence in Patients with Rheumatoid Arthritis Using Disease Modifying Antirheumatic Drugs by VAN DEN BEMT, Bart J. F, VAN DEN HOOGEN, Frank H. J, BENRAAD, Bart, HEKSTER, Yechiel A, VAN RIEL, Piet L. C. M, VAN LANKVELD, Wim

“…Objective. Nonadherence in patients with rheumatoid arthritis (RA) using disease modifying antirheumatic drugs (DMARD) may result in unnecessarily high levels…”
Get full text

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers by Weijers, Julia M., Semb, Anne G., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M.

“…The aim was to study the different strategies used to implement cardiovascular risk evaluation and management for patients with rheumatoid arthritis (RA) in…”
Get full text

Rituximab treatment in patients with refractory inflammatory myopathies by Mahler, Elien A. M., Blom, Marlies, Voermans, Nicol C., van Engelen, Baziel G. M., van Riel, Piet L. C. M., Vonk, Madelon C.

“…Objective. To assess the efficacy of rituximab on disease activity and muscle strength in patients with inflammatory myopathies refractory to conventional…”
Get full text

A replication study of the association between rheumatoid arthritis and deletion of the late cornified envelope genes LCE3B and LCE3C by Bergboer, Judith G M, Umićević-Mirkov, Maša, Fransen, Jaap, den Heijer, Martin, Franke, Barbara, van Riel, Piet L C M, Schalkwijk, Joost, Coenen, Marieke J H

“…Two recent studies, in a Spanish and a Chinese population, point to an association between rheumatoid arthritis (RA) risk and the deletion of the Late…”
Get full text